89Zr-bevacizumab

Known as: (89)Zr-bevacizumab, Zirconium Zr 89 Bevacizumab 
A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab labeled with the radioisotope zirconium Zr 89 (Zr 89… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2018
0204019952018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PURPOSE HSP90 chaperones have key client proteins that are involved in all hallmarks of breast cancer growth and progression. The… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
UNLABELLED Vascular endothelial growth factor (VEGF)-A is overexpressed in most malignant and premalignant breast lesions. VEGF-A… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Bevacizumab improves the efficacy of oxaliplatin-based chemotherapy in metastatic colorectal cancer. Our aim was to… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2010
2010
UNLABELLED Angiogenesis is a critical step in tumor development, in which vascular endothelial growth factor (VEGF) is a key… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE To compare the results of intravitreal bevacizumab (IVB) injection alone or in combination with intravitreal… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
To evaluate the use of preoperative intravitreal bevacizumab (IVB) in patients undergoing pars plana vitrectomy (PPV) for… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE To determine whether bevacizumab can reduce bleb failure in patients undergoing first-time trabeculectomy for primary… (More)
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • table 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
UNLABELLED Vascular endothelial growth factor (VEGF), released by tumor cells, is an important growth factor in tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To describe the pharmacokinetics of 1.25 mg of intravitreal bevacizumab (Avastin). DESIGN Experimental animal study… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To evaluate the efficacy and safety of photodynamic therapy (PDT) with verteporfin combined with intravitreal… (More)
Is this relevant?